News

Pfizer announced a partnership with IDA Foundation, an independent social enterprise providing essential medicines to low-and middle-income countries, to provide equitable access to quality cancer treatments in almost 70 developing countries across Latin America, Asia, Africa and the Western...

PHARMASEAL, a provider of clinical trial management and governance solutions, announced today that it has secured its first Medical Device customer – an award-winning US-based company providing ultrasound technology. The Engility® Trial Management Platform was chosen following review of several...

Raremark®, the global healthtech company specializing in rare disease, has today announced the appointment of Dale Jessop as Chief Technical Officer. Jessop brings a wealth of expertise and two decades worth of experience to the business, having worked for companies...

AbbVie and Caribou Biosciences, Inc., a leading clinical-stage CRISPR genome editing biotechnology company, announced that they have entered into a collaboration and license agreement for the research and development of chimeric antigen receptor (CAR)-T cell therapeutics. Although allogeneic, "off-the-shelf"...

Global contract development and manufacturing organisation (CDMO), Recipharm, has successfully extended its manufacturing license to include immunology products, allowing them to cater for customers’ vaccine products at clinical and commercial scales, in both freeze-dried and liquid forms. The license, which...

The U.S. FDA granted EUA for investigational bamlanivimab (LY-CoV555) 700 mg and etesevimab (LY-CoV016) 1400 mg together, Eli Lilly and Company announced. This therapy is authorized for the treatment of mild to moderate COVID-19 in patients aged 12 and...

Godrej & Boyce, the flagship company of the Godrej Group, has been contributing to making India self-reliant since its inception. Taking a step further towards building the nation’s healthcare infrastructure, Godrej & Boyce through its business unit Godrej Appliances,...